01—Abstract
Summary
Summary of the 10-K filed February 26, 2021. Cited figures are marked; the original filing is the authoritative source.
Ecolab Inc. (ECL) reported fiscal year 2020 sales of $11.8 billiona, a decrease of 6% from $12.6 billion in 2019, primarily attributed to the widespread impact of the COVID-19 pandemic.
While increased demand for hygiene products in the Healthcare & Life Sciences segment provided a boost, this was more than offset by declines in the Institutional & Specialty, Industrial, and Other segments due to reduced economic activity and mandated restrictions. The company faced a reported net loss of $1.2 billionb, or a loss of $4.15 per diluted share, a significant drop from the $1.6 billion net income in the prior year. This was heavily influenced by a substantial net loss from discontinued operations related to the separation of its Upstream Energy business (ChampionX).
Excluding special items and discrete tax impacts, adjusted diluted EPS from continuing operations was $4.02c, down from $5.12 in 2019, reflecting the challenging operating environment. Despite the headwinds, Ecolab maintained its commitment to returning capital to shareholders, increasing its quarterly dividend by 2% for the 29th consecutive year.
The company also continued to invest in its business through strategic acquisitions and emphasized its strong balance sheet and liquidity, with $1.26 billiond in cash and cash equivalents at year-end 2020. Management is focused on navigating the pandemic's ongoing effects and positioning the company for long-term growth through innovation and operational efficiency.
02—Key points
Key Highlights
- In 2020, Ecolab's reported sales decreased by 6% to $11.8 billion, primarily due to the negative impact of the COVID-19 pandemic on key customer segments like hospitality and foodservice.
- The company reported a net loss of $1.2 billion ($4.15 per diluted share) in 2020, largely impacted by a $2.17 billion loss from discontinued operations related to the separation of its Upstream Energy business (ChampionX).
- Adjusted diluted EPS from continuing operations declined to $4.02 from $5.12 in 2019, reflecting the challenging economic environment.
- The company increased its quarterly cash dividend by 2%, marking its 29th consecutive annual dividend increase.
- Ecolab maintained a strong balance sheet, with $1.26 billion in cash and cash equivalents at year-end 2020, and ended the year with $6.7 billion in outstanding debt.
- Significant special charges and restructuring activities totaling $312 million were recorded in 2020, impacting reported results.
- The Global Healthcare & Life Sciences segment showed robust growth, with sales increasing by 21% in 2020, driven by demand for hygiene and disinfection solutions.
03—One dollar
Follow one dollar
For each $1.00 of revenue in FY2020, Ecolab Inc. lost $0.10.
- Revenue$11.79B100.0%
- Cost of revenue−$6.91B58.6%
- Gross profit$4.88B41.4%
- Operating costs−$3.49B29.6%
- Operating income$1.40B11.8%
- Interest, other & tax−$2.60B22.1%
- Net income−$1.21B10.2%
Where FY2020 revenue went
$11.79B- Cost of revenue: $6.91B, 59% of revenue
- SG&A: $3.31B, 28% of revenue
- Operating income: $1.40B, 12% of revenue
- R&D: $185.0M, 1.6% of revenue
Kept 12% as operating income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2020filed February 26, 2021Financial Statements
FY2020 against FY2019
| Line item | FY2020FY2019 | Change |
|---|---|---|
| Revenue | $11.79B$12.56B | −6.1% |
| Cost of Revenue | $6.91B$7.05B | −2.0% |
| Gross Profit | $4.88B$5.52B | −11.5% |
| R&D Expenses | $185.00M$190.00M | −2.6% |
| SG&A Expenses | $3.31B$3.55B | −6.8% |
| Operating Income | $1.40B$1.85B | −24.4% |
| Interest Expense | $304.80M$214.40M | +42.2% |
| Net Income | -$1.21B$1.56B | −177.3% |
| EPS (Basic) | $-4.20$5.41 | −177.6% |
| EPS (Diluted) | $-4.15$5.33 | −177.9% |
| Shares Outstanding (Basic) | 287.00M288.10M | −0.4% |
| Shares Outstanding (Diluted) | 290.30M292.50M | −0.8% |
05—Questions
Frequently Asked Questions
How did the COVID-19 pandemic impact Ecolab's financial performance in 2020?
The COVID-19 pandemic had a significant negative impact on Ecolab's overall financial performance. While increased demand for hygiene and cleaning products benefited the Healthcare & Life Sciences segment, it was more than offset by reduced volumes in the Institutional & Specialty, Industrial, and Other segments due to mandated restrictions and lower economic activity, particularly affecting customers in the hospitality and foodservice industries. This resulted in lower sales and a significant decline in operating income and net income compared to 2019.
What was the impact of the ChampionX business separation on the 2020 results?
Ecolab completed the separation of its Upstream Energy business (ChampionX) in June 2020. This strategic shift required the company to report the historical results of ChampionX as discontinued operations. This resulted in a substantial net loss of $2.17 billion reported under discontinued operations for 2020, which heavily impacted the overall net loss for the year and diluted earnings per share.
What is Ecolab's strategy for returning capital to shareholders?
Ecolab has a strong commitment to returning capital to shareholders. In 2020, the company increased its quarterly cash dividend by 2%, marking its 29th consecutive annual dividend increase. The company also continued to repurchase shares to offset dilution from equity compensation plans and manage its capital structure, though share repurchases were lower in 2020 compared to prior years due to the challenging economic environment.
How is Ecolab managing its debt and liquidity?
Ecolab maintained a strong balance sheet and liquidity position. As of December 31, 2020, the company had $1.26 billion in cash and cash equivalents. Ecolab's credit ratings remained solid, allowing for continued access to capital at attractive rates. The company's net debt to EBITDA ratio was 2.4 for 2020, which it views as an indicator of financial health. Management expects to fund its cash requirements through operating cash flow and existing credit facilities.
06—Continue